We estimate that the President, CEO and Director of Jazz Pharmaceuticals plc ($JAZZ), Renee D. Gala, received a compensation of $19,151,558 in 2025. This is an increase of 65.39% from an estimated $6,628,888 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on June 08, 2026. Note that parsing errors may occur.
You can track $JAZZ on Quiver Quantitative's $JAZZ stock dashboard.
$JAZZ Stock Insider Trading Activity
$JAZZ Stock insiders have traded $JAZZ stock on the open market 29 times in the past 6 months. Of those trades, 0 have been purchases and 29 have been sales.
Here’s a breakdown of recent trading of $JAZZ stock by insiders over the last 6 months:
- NEENA M PATIL (EVP & Chief Legal Officer) has made 0 purchases and 12 sales selling 56,792 shares for an estimated $10,932,950.
- BRUCE C COZADD has made 0 purchases and 8 sales selling 24,000 shares for an estimated $4,892,323.
- SAMANTHA PEARCE (EVP, Chief Commercial Officer) sold 6,907 shares for an estimated $1,625,976
- MARY ELIZABETH HENDERSON (SVP, Technical Operations) has made 0 purchases and 2 sales selling 7,581 shares for an estimated $1,418,500.
- PATRICIA CARR (SVP, Chief Accounting Officer) has made 0 purchases and 3 sales selling 3,657 shares for an estimated $691,909.
- RICK E WINNINGHAM sold 2,741 shares for an estimated $662,143
- NORBERT G RIEDEL sold 3,415 shares for an estimated $655,680
- HEATHER ANN MCSHARRY sold 2,000 shares for an estimated $482,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$JAZZ Stock Hedge Fund Activity
We have seen 309 institutional investors add shares of $JAZZ Stock stock to their portfolio, and 290 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,474,837 shares (+184.1%) to their portfolio in Q1 2026, for an estimated $278,817,934
- CITADEL ADVISORS LLC added 948,324 shares (+304.8%) to their portfolio in Q1 2026, for an estimated $179,280,652
- JPMORGAN CHASE & CO removed 822,517 shares (-44.1%) from their portfolio in Q4 2025, for an estimated $139,827,890
- DIMENSIONAL FUND ADVISORS LP removed 728,088 shares (-27.8%) from their portfolio in Q1 2026, for an estimated $137,645,036
- BANK OF NEW YORK MELLON CORP added 517,514 shares (+44.5%) to their portfolio in Q1 2026, for an estimated $97,836,021
- PACER ADVISORS, INC. added 503,013 shares (+inf%) to their portfolio in Q1 2026, for an estimated $95,094,607
- AQR CAPITAL MANAGEMENT LLC added 461,191 shares (+52.6%) to their portfolio in Q1 2026, for an estimated $87,188,158
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$JAZZ Stock Analyst Ratings
Wall Street analysts have issued reports on $JAZZ in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 01/12/2026
To track analyst ratings and price targets for $JAZZ Stock, check out Quiver Quantitative's $JAZZ forecast page.
$JAZZ Stock Price Targets
Multiple analysts have issued price targets for $JAZZ recently. We have seen 12 analysts offer price targets for $JAZZ in the last 6 months, with a median target of $255.5.
Here are some recent targets:
- Etzer Darout from Barclays set a target price of $253.0 on 05/27/2026
- Jeffrey Walch from Bernstein set a target price of $229.0 on 05/22/2026
- David Amsellem from Piper Sandler set a target price of $301.0 on 05/22/2026
- Ashwani Verma from UBS set a target price of $307.0 on 05/19/2026
- Mohit Bansal from Wells Fargo set a target price of $265.0 on 05/06/2026
- Leonid Timashev from RBC Capital set a target price of $258.0 on 05/06/2026
- Joseph Thome from TD Cowen set a target price of $275.0 on 05/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
